ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 215 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $10,879,000 | -57.5% | 203,576 | -10.1% | 0.01% | -55.6% |
| Q4 2015 | $25,570,000 | -44.6% | 226,380 | -42.3% | 0.02% | -50.0% |
| Q3 2015 | $46,166,000 | +159.7% | 392,228 | +70.8% | 0.04% | +227.3% |
| Q2 2015 | $17,778,000 | +5.4% | 229,615 | -21.2% | 0.01% | +10.0% |
| Q1 2015 | $16,860,000 | +116.0% | 291,507 | +20.4% | 0.01% | +100.0% |
| Q4 2014 | $7,807,000 | +22.5% | 242,160 | -7.1% | 0.01% | +25.0% |
| Q3 2014 | $6,375,000 | +104.9% | 260,627 | +48.4% | 0.00% | +100.0% |
| Q2 2014 | $3,112,000 | -17.4% | 175,657 | -6.7% | 0.00% | -33.3% |
| Q1 2014 | $3,767,000 | +40.2% | 188,372 | +17.6% | 0.00% | +50.0% |
| Q4 2013 | $2,687,000 | +32.5% | 160,237 | -16.1% | 0.00% | +100.0% |
| Q3 2013 | $2,028,000 | – | 191,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |